Multiple Sclerosis Treatment and Melanoma Development

Therapy of multiple sclerosis (MS) with disease-modifying agents such as natalizumab or fingolimod has been associated with the development of cutaneous melanoma. Here we briefly revise literature data and report of a case of a 48-year old woman who developed a melanoma and several atypical naevi af...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Autores principales: Carbone, Maria Luigia, Lacal, Pedro Miguel, Messinese, Serena, De Giglio, Laura, Pozzilli, Carlo, Persechino, Severino, Mazzanti, Cinzia, Failla, Cristina Maria, Pagnanelli, Gianluca
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7216218/
https://ncbi.nlm.nih.gov/pubmed/32331328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21082950
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares